Join to view full profile
300 Mason Lord DriveKimmel Cancer CenterBaltimore, MD 21224
Phone+1 410-550-1711
Fax+1 410-550-1116
Dr. Forde is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2011 - 2014
Royal College of Surgeons IrelandClass of 2004
Certifications & Licensure
MD State Medical License 2014 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies Start of enrollment: 2015 Nov 23
- Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma Start of enrollment: 2017 Jun 13
- Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer Start of enrollment: 2017 Dec 12
Publications & Presentations
PubMed
- Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT.Filippo de Marinis, Tina Cascone, Patrick M Forde, Antonio Passaro, Heather Wakelee
Lung Cancer. 2026-09-01 - Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a CanonicalMutation: A Molecular Tumor Board Discussion.Ilias Ziakas, Amna Jamali, Michael Conroy, Katerina Karaindrou, Jaime Wehr
JCO Precision Oncology. 2026-07-01 - 1 citationsplasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.Jenna V Canzoniero, Daniel Rabizadeh, Ilias Ziakas, Jaime Wehr, Archana Balan
Clinical Cancer Research. 2026-05-01
Journal Articles
- Immuno-Oncology Trial Endpoints: Capturing Clinically Meaningful ActivityElad Sharon, Patrick M Forde, Valsamo Anagnostou, Hao Wang, Franco Verde, Mark Yarchoan, Clinical Cancer Research
Press Mentions
First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable MesotheliomaSeptember 8th, 2025- Treating Early-Stage Non-Small Cell Lung CancerAugust 19th, 2025
- Five-Year Study Reveals Immunotherapy Combined with Chemotherapy Before Lung Cancer Surgery Dramatically Enhances Long-Term SurvivalJune 3rd, 2025
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/patrick-forde
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
